AMRMX
Price
$57.98
Change
-$0.04 (-0.07%)
Updated
Jun 5 closing price
Net Assets
105.31B
RMEBX
Price
$57.64
Change
-$0.04 (-0.07%)
Updated
Jun 5 closing price
Net Assets
105.31B
Interact to see
Advertisement

AMRMX vs RMEBX

Header iconAMRMX vs RMEBX Comparison
Open Charts AMRMX vs RMEBXBanner chart's image
American Funds American Mutual A
Price$57.98
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets105.31B
American Funds American Mutual R2E
Price$57.64
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets105.31B
AMRMX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AMRMX vs. RMEBX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRMX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AMRMX (105B) and RMEBX (105B) have equal amount of cash in the bank . AMRMX pays higher dividends than RMEBX: AMRMX (1.61) vs RMEBX (1.16). AMRMX was incepted earlier than RMEBX: AMRMX (75 years) vs RMEBX (11 years). RMEBX (1.07) is less costly to investors than AMRMX (0.58). AMRMX (31.00) and RMEBX (31.00) have comparable annual turnover. AMRMX (250) and RMEBX (250) have matching initial minimum investment requirements. AMRMX annual gain was more profitable for investors over the last year : 8.86 vs. RMEBX (8.30). AMRMX return over 5 years is better than : 53.60 vs. RMEBX (49.85).
AMRMXRMEBXAMRMX / RMEBX
Total Expense Ratio0.581.0754%
Annual Report Gross Expense Ratio0.581.0754%
Fund Existence75 years11 years-
Gain YTD5.5635.349104%
Front Load6%N/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets105B105B100%
Annual Yield % from dividends1.611.16139%
Returns for 1 year8.868.30107%
Returns for 3 years19.7417.96110%
Returns for 5 years53.6049.85108%
Returns for 10 years73.2268.21107%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV5.720.43
+8.22%
Verve Therapeutics
VRNT18.780.97
+5.45%
Verint Systems
CHRS0.80N/A
+0.48%
Coherus Oncology Inc
CHSCN25.15-0.05
-0.20%
CHS
PRI265.13-2.99
-1.12%
PRIMERICA